BioRestorative Net Debt To E B I T D A from 2010 to 2025

BRTX Stock  USD 1.52  0.10  6.17%   
BioRestorative Therapies Net Debt To EBITDA yearly trend continues to be fairly stable with very little volatility. Net Debt To EBITDA is likely to outpace its year average in 2025. Net Debt To EBITDA is a leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company's net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). View All Fundamentals
 
Net Debt To EBITDA  
First Reported
2010-12-31
Previous Quarter
0.0432
Current Value
0.0453
Quarterly Volatility
0.51617594
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check BioRestorative Therapies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioRestorative Therapies' main balance sheet or income statement drivers, such as Interest Expense of 12.7 K, Selling General Administrative of 7.7 M or Depreciation And Amortization of 178.1 K, as well as many indicators such as Price To Sales Ratio of 54.99, Dividend Yield of 0.0 or PTB Ratio of 0.69. BioRestorative financial statements analysis is a perfect complement when working with BioRestorative Therapies Valuation or Volatility modules.
  
Check out the analysis of BioRestorative Therapies Correlation against competitors.
For more information on how to buy BioRestorative Stock please use our How to Invest in BioRestorative Therapies guide.

Latest BioRestorative Therapies' Net Debt To E B I T D A Growth Pattern

Below is the plot of the Net Debt To E B I T D A of BioRestorative Therapies over the last few years. It is a leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company's net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). BioRestorative Therapies' Net Debt To EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioRestorative Therapies' overall financial position and show how it may be relating to other accounts over time.
Net Debt To E B I T D A10 Years Trend
Slightly volatile
   Net Debt To E B I T D A   
       Timeline  

BioRestorative Net Debt To E B I T D A Regression Statistics

Arithmetic Mean(0.35)
Coefficient Of Variation(145.99)
Mean Deviation0.40
Median(0.28)
Standard Deviation0.52
Sample Variance0.27
Range1.9464
R-Value0.68
Mean Square Error0.15
R-Squared0.46
Significance0
Slope0.07
Total Sum of Squares4.00

BioRestorative Net Debt To E B I T D A History

2025 0.0453
2024 0.0432
2023 0.048
2022 0.0729
2021 0.78
2020 -0.18
2019 -0.83

About BioRestorative Therapies Financial Statements

BioRestorative Therapies investors use historical fundamental indicators, such as BioRestorative Therapies' Net Debt To E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioRestorative Therapies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Debt To EBITDA 0.04  0.05 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BioRestorative Stock Analysis

When running BioRestorative Therapies' price analysis, check to measure BioRestorative Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRestorative Therapies is operating at the current time. Most of BioRestorative Therapies' value examination focuses on studying past and present price action to predict the probability of BioRestorative Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRestorative Therapies' price. Additionally, you may evaluate how the addition of BioRestorative Therapies to your portfolios can decrease your overall portfolio volatility.